Objective:
To assess refractive and astigmatic outcomes after PRK in eyes with moderate or high preoperative astigmatism and identify factors associated with residual astigmatism.
Approach:
- Study design and participants: Retrospective, single-center evaluation of 112 eyes from 71 patients treated with PRK between May 2018 and March 2019: 69 eyes had moderate astigmatism (3.00–3.99 D) and 43 had high astigmatism (≥4.00 D).
- Treatment and assessment: All eyes received non–wavefront-guided, aberration-free excimer laser ablation planned from manifest refraction. Visual acuity, refraction, safety and efficacy indices, and astigmatic vector outcomes were assessed through 12 months.
Key Findings:
- Mean cylinder decreased from −3.76 D before surgery to −0.40 D at 12 months. At final follow-up, 76% of eyes were within 0.50 D and 96% within 1.00 D of the intended spherical equivalent target.
- At 12 months, residual cylinder was ≤0.50 D in 64% of moderate-astigmatism eyes versus 28% of high-astigmatism eyes; residual cylinder >1.00 D occurred in 7% versus 30%, respectively.
- The mean difference vector was 0.59 D in the moderate group and 0.97 D in the high group. Overall correction index was 1.07, indicating a slight tendency toward overcorrection in astigmatic magnitude.
- UDVA better than 20/40 was achieved in 97% of eyes; mean efficacy and safety indices were 0.92 and 0.99. Angular accuracy was within 5 degrees in 71% and within 15 degrees in all eyes.
- Higher preoperative cylinder and poorer preoperative corrected distance visual acuity were independently associated with greater residual astigmatism. Preoperative spherical refractive error was not independently associated.
Interpretation:
The study authors reported favorable overall visual and refractive outcomes, while eyes with higher baseline astigmatism had less precise cylinder correction. Longer mitomycin C application was associated with greater residual astigmatism, but the authors cautioned that this likely reflected confounding by indication.
Limitations:
- Retrospective, single-center design, relatively small sample, and no control group.
- Forty-one patients contributed both eyes, and follow-up was limited to 12 months, restricting assessment of long-term refractive stability.
- The observational design and treatment-dependent mitomycin C exposure do not support causal conclusions about associated factors.
Sources:
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
